Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier ...
Walgreens Boots ( NASDAQ: WBA) pared a bit of its decline amid a report that private equity firm Sycamore Partners is talking to private equity confirms about debt financing for a potential takeover.
Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...
Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In fact, according to reporting from Bloomberg and The Financial Times in 2019, ...
Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely to sell itself to a private-equity firm. CNBC’s David Faber reported on ...
Walgreens Boots Alliance Inc. shares fell sharply Monday after CNBC reported that a potential take-private deal with Sycamore Partners LLC is unlikely. Sycamore was reportedly in talks to purchase the ...
The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be finalized early this year.
Walgreens Boots (NASDAQ:WBA) fell 6.6% on a report that a potential takeover by private equity from Sycamore Partners is likely not going to happen. "It's mostly dead," CNBC's David Faber said on ...
Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...
Anya is a freelance credit cards writer and adventurer based in Salt Lake City. She has written about award travel, rewards credit cards and personal finance extensively for NerdWallet, 10xTravel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results